Literature DB >> 30083338

Screening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population-based program: A nested case-control study.

Eunate Arana-Arri1,2, Natale Imaz-Ayo1, Mari Jose Fernández3, Isabel Idigoras1,3, Isabel Bilbao1,3, Luis Bujanda4,5, Fidencio Bao1,6, Enrique Ojembarrena1,2, Ines Gil4,5, Iñaki Gutiérrez-Ibarluzea7, Isabel Portillo1,3.   

Abstract

BACKGROUND: Screening by means of biennial fecal occult blood test has provided a reduction in overall colorectal cancer mortality. Notwithstanding, we should not underestimate the harms that it can produce. AIM: The aim of this article is to identify the independent risk factors of complications after a screening colonoscopy.
METHODS: A six-year, nested case-control study was conducted. Mortality/complications within 30 days after colonoscopy were registered and its predictors identified through logistic regression.
RESULTS: After 39,254 colonoscopies, the complication rate was 1.0%. Independent predictors were sex (OR 1.68 for men; CI 95% 1.18-2.39), ASA physical status classification system (OR 1.73 for ASA II-III; CI 95% 1.53-3.69), history of abdominal surgery (OR 2.37; CI 95% 1.72-4.08), diverticulosis (OR 2.89; CI 95% 1.94-4.30), inadequate cleansing (OR 29.35; CI 95% 6.52-132.17), detection of advanced neoplasia (AN) (OR 4.92; CI 95% 3.29-7.36), detection of stage I adenocarcinoma (OR 9.44; CI 95% 4.46-20.0), polyps in right colon OR 2.27 CI 95% 1.38-3.74) and complex polypectomy (OR 2.00; CI 95% 1.25-3.20). The logistic model explained 82% of the complications (CI 95% 0.798-0.854, p < 0.001).
CONCLUSIONS: Colonoscopy, with or without removal of a lesion, is an invasive procedure with a non-deniable risk of major complications. Factors like inadequate cleansing or detection of AN are determinants. Therefore, it is vital to know which aspects predict their appearance to implement countermeasures.

Entities:  

Keywords:  Colorectal cancer; complication; fecal immunochemical test; independent risk factors; screening colonoscopy

Year:  2018        PMID: 30083338      PMCID: PMC6068784          DOI: 10.1177/2050640618756105

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  34 in total

1.  Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.

Authors:  Thomas J W Lee; Matthew D Rutter; Roger G Blanks; Sue M Moss; Andrew F Goddard; Andrew Chilton; Claire Nickerson; Richard J Q McNally; Julietta Patnick; Colin J Rees
Journal:  Gut       Date:  2011-09-22       Impact factor: 23.059

2.  Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening Programme.

Authors:  Matthew D Rutter; Claire Nickerson; Colin J Rees; Julietta Patnick; Roger G Blanks
Journal:  Endoscopy       Date:  2014-01-29       Impact factor: 10.093

Review 3.  Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies.

Authors:  Ankie Reumkens; Eveline J A Rondagh; C Minke Bakker; Bjorn Winkens; Ad A M Masclee; Silvia Sanduleanu
Journal:  Am J Gastroenterol       Date:  2016-06-14       Impact factor: 10.864

4.  Complex colon polypectomy.

Authors:  Juan F Gallegos-Orozco; Suryakanth R Gurudu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-06

5.  Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study.

Authors:  Hermann Brenner; Jenny Chang-Claude; Christoph M Seiler; Til Stürmer; Michael Hoffmeister
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

6.  Long-term mortality after screening for colorectal cancer.

Authors:  Aasma Shaukat; Steven J Mongin; Mindy S Geisser; Frank A Lederle; John H Bond; Jack S Mandel; Timothy R Church
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

7.  Impact of bowel preparation on efficiency and cost of colonoscopy.

Authors:  Douglas K Rex; Thomas F Imperiale; Danielle R Latinovich; L Lisa Bratcher
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

8.  Efficacy, risk factors and complications of endoscopic polypectomy: ten year experience at a single center.

Authors:  Pierluigi Consolo; Carmelo Luigiano; Giuseppe Strangio; Maria-Grazia Scaffidi; Giuseppa Giacobbe; Giovanna Di Giuseppe; Agata Zirilli; Luigi Familiari
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

Review 9.  Cost-effectiveness of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Epidemiol Rev       Date:  2011-06-01       Impact factor: 6.222

10.  UK key performance indicators and quality assurance standards for colonoscopy.

Authors:  Colin J Rees; Siwan Thomas Gibson; Matt D Rutter; Phil Baragwanath; Rupert Pullan; Mark Feeney; Neil Haslam
Journal:  Gut       Date:  2016-08-16       Impact factor: 23.059

View more
  7 in total

1.  A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients.

Authors:  Oiana Telleria; Oihane E Alboniga; Marc Clos-Garcia; Beatriz Nafría-Jimenez; Joaquin Cubiella; Luis Bujanda; Juan Manuel Falcón-Pérez
Journal:  Metabolites       Date:  2022-06-15

2.  Analysis of the Characteristics of Colonoscopy Perforation and Risk Factors for Failure of Endoscopic Treatment.

Authors:  Zhi Jiehua; Ali Kashif; Che YaoSheng; Sun YunYun; Liang Lanyu
Journal:  Cureus       Date:  2022-06-05

3.  Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort.

Authors:  Elizabeth A Kobe; Brian A Sullivan; Xuejun Qin; Thomas S Redding; Elizabeth R Hauser; Ashton N Madison; Cameron Miller; Jimmy T Efird; Ziad F Gellad; David Weiss; Kellie J Sims; Christina D Williams; David A Lieberman; Dawn Provenzale
Journal:  Gastrointest Endosc       Date:  2022-05-07       Impact factor: 10.396

4.  Evaluation of colonoscopy data for colorectal polyps and associated histopathological findings.

Authors:  Mohammad Kazem Shahmoradi; Maryam Soleimaninejad; Masoud Sharifian
Journal:  Ann Med Surg (Lond)       Date:  2020-07-11

Review 5.  Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.

Authors:  Gergely Buglyó; Jakub Styk; Ondrej Pös; Ádám Csók; Vanda Repiska; Beáta Soltész; Tomas Szemes; Bálint Nagy
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

6.  Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program.

Authors:  Ellen M Mikkelsen; Mette Kielsholm Thomsen; Julie Tybjerg; Lennart Friis-Hansen; Berit Andersen; Jens Christian Riis Jørgensen; Gunnar Baatrup; Sisse H Njor; Frank Mehnert; Morten Rasmussen
Journal:  Clin Epidemiol       Date:  2018-11-13       Impact factor: 4.790

7.  Adverse events of colonoscopy in a colorectal cancer screening program with fecal immunochemical testing: a population-based observational study.

Authors:  Bernard Denis; Isabelle Gendre; Sarah Weber; Philippe Perrin
Journal:  Endosc Int Open       Date:  2021-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.